Search

everythinglearnresearchcommunity

for

Search:↓

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Baricitinib may not always prevent relapse in alopecia areata.

Upadacitinib may effectively treat resistant lichen planopilaris.

Baricitinib successfully treated severe hair loss.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Tofacitinib helped regrow hair in a teen with a unique pattern of alopecia areata.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.